By the end of 2018, through 10 years of continuous research and development, we have successfully developed : Small molecule targeted anti-tumor products: 21 projects ,such as Gefitinib, Erlotinib, Pazopanib, Lapatinib, Afatinib, Lenvatinib,etc; Diabetes products: 16 items ,such as Sitagliptin, Linagliptin,Alogliptin, Dapagliflozin, and Canagliflozin,etc; Anti-Cardiovascular products: 7 projects ,including Apixaban, Rivaroxaban, Betrixaban, and Dofetilide;
ANQING CHICO PHARMACEUTICAL CO.,LTD.
Country: 
China (Mainland)
Business Type: Trading Company
Premiumsupplier
Ms.JIANG
Tel: +86-13057662806
(2R,3R,4R,5S,6S)-2-(acetoxylmethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyltriacetateCAS NO.: 461432-25-7
(E)-Ethyl 2-cyano-3-ethoxyacrylateCAS NO.: 42466-67-1
N4-(3-chloro-4-fluorophenyl)-7-(3-morpholinopropoxy)quinazoline-4,6-diamineCAS NO.: 267243-68-5
2-(5-BroMo-2-Methylbenzyl)-5-(4-fluorophenyl)thiopheneCAS NO.: 1030825-20-7
Ethyl 4-methyl-5-thiazoleactateCAS NO.: 20582-55-2
(S)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diaMineCAS NO.: 314771-76-1
(R)-4-(5-chlorobenzo[d]oxazol-2-yl)-7-Methyl-1,4-diazepan-1-iuM (2S,3S)-2,3-bis(benzoyloxy)-3-carboxypropanoateCAS NO.: 1276666-14-8
3-Cyclopropyl-1-(2-fluoro-4-iodophenyl)-6-methylamino-1H-pyrimidine-2,4-dioneCAS NO.: 871700-22-0
dabrafenib mesylateCAS NO.: 1195768-06-9
D-Gluconic acid, δ-lactone, 2,3,4,6-tetraacetateCAS NO.: 61259-48-1
